| INTRODUCTION
Markers of lipid metabolism and glucose homeostasis are used in the assessment of energy metabolism in both the clinical practice and research of dogs. For example, the diagnosis and follow-up of diabetes mellitus (DM) relies on glucose and fructosamine measurements. 1, 2 Canine obesity-related metabolic dysfunction (ORMD) is also associated with dyslipidemia and glucose intolerance, while subclinical inflammation also seems to play a role in this disease. [3] [4] [5] [6] [7] When interpreting laboratory results, species-specific reference intervals (RIs) are used to identify abnormal values. However, withinspecies genotypic variation can also significantly influence phenotypes. [8] [9] [10] [11] [12] [13] [14] [15] Indeed, differences in expected values of biochemical analytes associated to ORMD have been reported for certain canine breeds, such as lower cholesterol and insulin concentrations in Miniature Dachshunds, 16, 17 and higher free fatty acids (FFA) and cholesterol concentrations in Shetland Sheepdogs. 16, 18 Healthy
Miniature Schnauzer dogs have been reported to have higher triglyceride, cholesterol, and C-reactive protein (CRP) concentrations than dogs of other breeds. 16, 17, 19, 20 Breed-specific RIs are, therefore, gaining importance as an improved tool for a more accurate interpretation of laboratory data in dogs. The biomarkers of glucose and lipid homeostasis are, furthermore, strongly influenced by diet, which makes interpretation of these results even more challenging. The objective of the present study was to investigate physiologic interbreed variation in biomarkers related to ORMD among healthy dogs, fed commercial dry-food diets.
| MATERIALS AND METHODS
A database created during the European LUPA project 21 was retrospectively investigated for the present study. The main goal of the initial project was to unravel the genetic determinants of biochemical variable variation in healthy dogs. Five centers were involved in the study: the University of Liège, the University of Copenhagen, the Swedish University of Agricultural Sciences, the University of Helsinki, and the National Veterinary School of Maisons-Alfort. Each center followed the same standardized protocol, which was approved in each country by an Ethical Committee. 
| Inclusion criteria

| Health status
Dogs that fit the conditions were subject to a health check and were considered healthy based on history, clinical examination, complete blood count, biochemical analysis, and cardiovascular work-up. A body condition score (BCS) was assessed using a 1-to 9-point scale, 22 by means of visual inspection and palpation.
| Exclusion criteria
Dogs were excluded from the study if there was any finding that indicated systemic or organ-related disease, including obesity (BCS >7/9). 
| Sampling
Owners were instructed to feed only commercial dog food and no treats during the 2 weeks before participation, and the dogs were fasted for at least 12 hours before blood sampling. Each cohort was examined in a similar situation, avoiding stress.
Blood was collected in serum tubes that were centrifuged within 30 minutes. Serum was transferred into plastic cryotubes and frozen at −80°C. For practical reasons, one center kept the tubes at −20°C during a 2-week period, and then transferred them frozen at −80°C.
Samples were then transported frozen on dry ice at −80°C to the laboratory. Assays were performed within one year after blood collection.
| Analyses
Among all variables included in our database, for this study, we selected markers of lipid metabolism (cholesterol, TG, and FFA), glucose homeostasis (glucose, fructosamine, and insulin), and inflammation (CRP), all of which have been previously associated with ORMD in dogs [3] [4] [5] [6] [7] and humans. 24, 25 Fructosamine, glucose, CRP, cholesterol, TG, and FFA were assayed using a Konelab 60i (Thermo Electron Co, Vantaa, Finland).
We used kits for the fructosamine and FFA assays from the Hariba ABX (Montpellier, France) and Wako Chemicals GmbH (Neuss, Germany) companies, respectively. Insulin was measured using a radioimmunoassay method (DiaSorin SpA, Italy).
| The repeatability of measurements
The samples of 10 randomly chosen dogs were analyzed in duplicate and then analyzed again 3 months later. Coefficients of variation were ≤5% for FFA, cholesterol, TG, glucose, and fructosamine, and 6% for insulin.
| Statistical analyses
Data were examined for the presence of outliers by applying the and glucose, for which only a few significant interbreed differences were found. In the centers where more than one breed was tested, interbreed comparisons continued to show significant differences for all variables, except for CRP.
Serum fructosamine concentrations differed considerably between breeds. DOBs had the lowest concentrations, and NFs had the highest concentrations, with a difference of 70 µmol/L between the breeds. This is more than twice the difference that has been shown to be critical between two consecutive week-to-week measurements (two different studies reported, 32.4 and 33.5 µmol/L, respectively). 29, 30 Fructosamine is a product of protein glycation, and it reflects the glycemia of the previous weeks. 31 In canine medicine, fructosamine is especially useful in monitoring DM. 2 Even though the different breed concentrations remained within the previously established RIs, 29,32-34 our findings support the need for breedspecific RIs for serum fructosamine concentrations. A previous article using the same dog population identified two loci involved in fructosamine regulation in BS. 35 It was hypothesized that this finding could be connected to protective mechanisms against DM, a disease that is not frequently encountered in this breed. The study did not find any other associations between biochemical concentrations of the different variables and the genotype of any of the other breeds tested.
Insulin concentrations in the DOBs and FLs were significantly higher than in all other breeds except for the BSs. The median insulin concentration was more than 50% higher in the DOBs and the FLs as compared with that of the BOXs, which was the breed with the lowest median insulin concentration. A previous study found lower insulin concentrations in Miniature Dachshunds compared with those of control dogs. 16 In our study, the DACHs had low insulin concentrations, and they differed significantly from the higher values of the DOBs and FLs. These strong interbreed insulin concentration differences warrant further research.
The highest median cholesterol concentration was found in the NFs. BOX cholesterol concentrations approached those of the NFs and were significantly different from GSs and DACHs.
The DACHs had the lowest cholesterol concentrations among all the breeds tested. This is in accordance with a previous study in LABs. 36 The latter agreed with a previous finding. 37 LAB cholesterol concentrations were not outstanding in the present study.
Even though all breeds included in our study remained within previously published RIs for cholesterol, 33 the interbreed differences were sometimes large (eg, median NF and BOX cholesterol concentrations were more than 1.7 times those of the DACHs).
Therefore, breed-specific RIs could reasonably increase the accuracy of this biomarker.
TGs were significantly higher in NFs, FLs, and DOBs than in several other breeds. DACHs and BOXs had the lowest TG median concentration. However, in both cases, the variations found in our study were very mild.
Newfoundland CRP concentrations were significantly higher compared with those of all other breeds, and LABs had significantly higher serum CRP concentrations compared with CKCS. CRP is a sensitive marker of inflammation, which has been linked to obesity in humans 25 and dogs, although the findings in the canine species differed among studies. 7, 38 A previous article 20 found slightly higher CRP concentrations in Miniature Schnauzers as compared with dogs from other breeds, which may suggest a possible relationship with hyperlipidemia in this breed. In the present study, not only the highest CRP, but also the highest TG, cholesterol, and fructosamine concentrations were observed in NF, which may provide a physiologic link between these biomarkers in dogs. In the case of NF, they could be an example of physiologic adaptations to the original environment of the breed, which included cold temperatures and work as water rescue dogs. In both humans and dogs, all these variables have been associated with obesity, [3] [4] [5] 24, 25 and NF dogs are among the canine breeds predisposed to obesity. 23 However, in the present study, other breeds that were previously reported to be predisposed to obesity did not show outstanding concentrations of these analytes (LAB), and some breeds even showed low median concentrations (DACH).
In addition to the differences in single biochemical variables, we observed what seemed to be breed-specific physiological patterns. 
| Limitations
The first limitation of our study was the uneven sex distribution.
Except for LABs, all other breeds included only one sex. This design is explained by the original aim of the LUPA project, which looked for genetic determinants of phenotypic variation in healthy dogs.
Genetic analyses are easier to perform in homogeneous populations using only one sex. For the same reason, breed-specific RIs could not be generated following latest recommendations. 26 Nevertheless, this did not affect the goal of this particular study, which was to show evidence of physiologic interbreed variation in a population of client-owned, healthy dogs, representative of the true clinical picture.
Because many breed cohorts were covariate with the center where the dogs had been examined, there existed a potential risk of mistaking environmental conditions for breed-associated effects.
However, data were collected prospectively, and extreme care was taken as to standardize the conditions in all centers so that an important environmental influence was avoided. Furthermore, interbreed differences were demonstrated within centers that examined several breeds, proving that variation does exist regardless of the geographic location. The only variable that did not show significant interbreed differences within any single center was CRP. However, this does not invalidate our results regarding differences in CRP. In the present study, glucose values were also rounded up to only one decimal place. This lessened the statistical power. Nevertheless, finding significant results despite this limitation further reinforces our results. Very slight, significant differences in glucose concentrations between the breeds were found. Interestingly, the Dunn's test reported significant differences between some breeds with the same medians. This test carries out pairwise comparisons after the KW test has identified an overall difference. 39 It does not actually compare medians, but rather distributions, to which it is especially sensitive. Therefore, two populations with the same medians but different distributions may be considered significantly different. 40 This approach was chosen for this study because the actual goal was not to look for different medians, but rather the probability of getting higher or lower values when taking random samples from either one of the breeds. Furthermore, given our sample size and the fact that we used a strictly conservative Bonferroni correction for multiple comparisons, we believe that the significant differences found do hold information about interbreed differences.
Statistical outliers were present, but were kept because they were considered compatible with physiological concentrations in dogs, and no more than one outstanding value was found, at most, per dog. Guidelines on breed-specific RIs insist that all efforts should be made to preserve the outliers unless biological abnormalities are evidenced. In addition, outliers have less influence when nonparametric tests (ie, KW) are used. 26 In conclusion, this study provides further evidence that significant interbreed differences exist concerning serum concentrations of markers of lipid and glucose metabolism in dogs. This should be considered when interpreting laboratory data in both research and clinical decision-making. Fructosamine, insulin, and cholesterol showed wide variations, suggesting that the use of breed-specific RIs would greatly increase the accuracy of these biomarkers.
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